Yeah I've got nothing to counter you with. I'm disappointed. There are some positive and negatives I take from this however.
Positives: Money to float the company for a substantial time, massive focus on production for some reason im sure will be disclosed shortly
Negatives: Possible massive dilution, more director compensation for nil results, low expectations by directors regarding growth for the next 3 years (unless they've left them extremely gettable purposely to line their own pockets)
I am hopeful this is backed up with some positive announcements regarding $$$'s. There's a few missing pieces to the announcement today that need filling. I will wait to hear what they are.
- Forums
- ASX - By Stock
- GMV
- Ann: Notice of Annual General Meeting
Ann: Notice of Annual General Meeting, page-45
-
-
- There are more pages in this discussion • 408 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online